[{"Assets_0_Q3_USD":1758418000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":54257000.0,"NetIncomeLoss_1_Q3_USD":6970000.0,"NetIncomeLoss_3_Q3_USD":13686000.0,"StockholdersEquity_0_Q3_USD":700922000.0,"EarningsPerShareBasic_1_Q3_USD":0.25,"EarningsPerShareBasic_3_Q3_USD":0.48,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":28353000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":28280000.0,"Ticker":"CNMD","CIK":"816956","name":"CONMED CORP","OfficialName":"CONMED Corporation Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4404922313.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20191031"}]